Standout Papers

Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With <s... 2018 2026 2020 2023 258
  1. Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial (2018)
    Jonathan Strosberg, Edward M. Wolin et al. Journal of Clinical Oncology

Immediate Impact

1 from Science/Nature 52 standout
Sub-graph 1 of 19

Citing Papers

Metabolic reprogramming in the tumor microenvironment of liver cancer
2024 Standout
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
3 intermediate papers

Works of Thomas Thevenet being referenced

Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial
2018 Standout

Author Peers

Author Last Decade Papers Cites
Thomas Thevenet 202 223 149 7 273
A Sankowski 227 245 158 12 317
J. Augui 156 183 95 6 268
Jade Xiao Jue Soh 204 242 174 6 278
Julia Janssen 138 157 115 5 227
Amar B. Shah 97 134 93 11 272
Janet Lasher 185 215 135 8 331
Anela Blažević 233 250 168 13 301
Taylor K. Blair 161 132 70 10 293
Stefan Senftleben 117 132 74 6 303
Katarzyna Fröss‐Baron 156 191 134 12 287

All Works

Loading papers...

Rankless by CCL
2026